Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Abbott Diagnostics
Point Of Care Diagnostics Market Projected To Continue Rapid Growth
A new report from Informa's Meddevicetracker highlights strong projected growth in the market, explaining the underlying reasons why.
Abbott, BD, Quidel OTC COVID-19 Tests Granted Emergency Use Authorization In US
FDA grants emergency use authorization to OTC COVID-19 testing products as it targets allowing workplaces, schools and communities to access tools needed to screen for the virus rapidly and accurately.
FDA Grants Emergency Use Authorization To Variety Of OTC COVID-19 Tests
The US agency has granted emergency use authorization to consumer COVID-19 testing products from Quidel, Abbott and BD.
COVID-19 Registry Aims To Map And Address Potential Test Shortages
Medtech industry group AdvaMed has developed a registry to share data on how many COVID-19 diagnostic tests are available and where they are, with a goal of foreseeing and nipping in the bud potential test shortages. Thirteen diagnostic manufacturers – including Abbott, Roche, Siemens and Thermo Fisher Scientific – have partnered with AdvaMed on the initiative.
- In Vitro Diagnostics
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.